- Filed
- May 4, 2021 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2021 · Apr 27, 2021 | 33.29M sh |
| Cash And Equivalents | Q1 2021 · Mar 31, 2021 | $42.58M |
| Cash And Equivalents | Q1 2021 · Dec 31, 2020 | $40.32M |
| Current Liabilities | Q1 2021 · Mar 31, 2021 | $271.83M |
| Current Liabilities | Q1 2021 · Dec 31, 2020 | $274.65M |
| Total Liabilities | Q1 2021 · Mar 31, 2021 | $982.3M |
| Total Liabilities | Q1 2021 · Dec 31, 2020 | $1.01B |
| Current Assets | Q1 2021 · Mar 31, 2021 | $422.75M |
| Current Assets | Q1 2021 · Dec 31, 2020 | $429.37M |
| Total Assets | Q1 2021 · Mar 31, 2021 | $1.25B |
| Total Assets | Q1 2021 · Dec 31, 2020 | $1.3B |
| Shares Diluted | Q1 2021 · Mar 31, 2020 | 32.65M sh |
| Stock Repurchased | Q1 2021 · Mar 31, 2020 | $835K |
| Capex restated | Q1 2021 · Mar 31, 2020 | $16.81M |
| Operating Cash Flow | Q1 2021 · Mar 31, 2020 | $8.27M |
| Stockholders Equity | Q1 2021 · Mar 31, 2020 | $379.63M |
| Stockholders Equity | Q1 2021 · Dec 31, 2019 | $409.54M |
| Sga Expense restated | Q1 2021 · Mar 31, 2020 | $33.56M |
| Net Income | Q1 2021 · Mar 31, 2020 | −$18.3M |
| Cost Of Revenue | Q1 2021 · Mar 31, 2020 | $91.57M |
| Revenue restated | Q1 2021 · Mar 31, 2020 | $160.79M |